Related Experiment Video
Updated: Aug 27, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.3K
[New developments in headache management in 2022].
Ludovico Della Vedova1, Pouya Hashemi1, Anne Meynard-Colomb2
1Service de médecine de premier recours, Département de médecine de premier recours, Hôpitaux universitaires de Genève, 12011 Genève 14.
Revue Medicale Suisse
|September 28, 2022
Summary
Headache classification and severity criteria have been updated to improve diagnosis. New treatments like CGRP antagonists and integrative medicine offer better management for severe migraines and other headache types.
Area of Science:
- Neurology
- Primary Care Medicine
- Clinical Diagnostics
Background:
- Headaches are a frequent reason for primary care visits, necessitating accurate classification and identification of severe etiologies.
- The polymorphic nature of headaches demands precise diagnostic tools and assessment for red flags.
- Recent advancements aim to refine headache diagnosis and management strategies in clinical practice.
Purpose of the Study:
- To highlight the importance of accurate headache classification and severity assessment in primary care.
- To introduce the International Classification of Headache Disorders, 3rd version (ICHD-3) and SNNOOP10 severity criteria.
- To discuss emerging concepts like 'green flags' and novel therapeutic approaches for headache management.
Main Methods:
- Review of the International Classification of Headache Disorders, 3rd version (ICHD-3) criteria.
- Analysis of the revised SNNOOP10 severity criteria for headache assessment.
- Exploration of the concept of 'green flags' for primary headache diagnosis.
- Overview of CGRP neuropeptide antagonists in migraine treatment.
- Discussion of the role of integrative medicine in headache care.
Main Results:
- The ICHD-3 provides a standardized framework for headache classification.
- SNNOOP10 offers validated criteria for assessing headache severity.
- 'Green flags' aid in identifying primary headaches, potentially reducing unnecessary investigations.
- CGRP antagonists represent a significant therapeutic advance for severe migraine forms.
- Integrative medicine is increasingly recognized as a valuable component of headache management.
Conclusions:
- Updated classification systems and severity criteria improve headache diagnosis and management.
- Novel pharmacological and non-pharmacological approaches enhance treatment options for various headache disorders.
- A comprehensive approach integrating diagnostic tools, severity assessment, and diverse treatments is crucial for effective headache care.
Related Concept Videos
01:25Analgesia and Pain Management
763
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
763
01:23Hypertension V: Nursing Management
30
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
30
01:26Tonsillitis II: Management
162
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
162
01:27Open Angle Glaucoma: Treatment
527
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
527
01:19Management of Insomnia
312
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
312
01:28Angle Closure Glaucoma: Treatment
628
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
628